Page last updated: 2024-08-24

zileuton and Diabetic Nephropathies

zileuton has been researched along with Diabetic Nephropathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badr, KF; Montero, A; Munger, KA; Valdivielso, JM	1

Other Studies

1 other study(ies) available for zileuton and Diabetic Nephropathies

Article	Year
Inhibition of 5-LO activating protein (FLAP) activity decreases proteinuria in streptozotocin (STZ)-induced diabetic rats. Advances in experimental medicine and biology, 2002, Volume: 507 Topics: 5-Lipoxygenase-Activating Proteins; Animals; Blood Glucose; Blood Urea Nitrogen; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diuresis; Hydroxyurea; Lipoxygenase Inhibitors; Male; Membrane Proteins; Proteinuria; Quinolines; Rats; Rats, Sprague-Dawley	2002

Article

Year

Inhibition of 5-LO activating protein (FLAP) activity decreases proteinuria in streptozotocin (STZ)-induced diabetic rats.

Advances in experimental medicine and biology, 2002, Volume: 507

Topics: 5-Lipoxygenase-Activating Proteins; Animals; Blood Glucose; Blood Urea Nitrogen; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diuresis; Hydroxyurea; Lipoxygenase Inhibitors; Male; Membrane Proteins; Proteinuria; Quinolines; Rats; Rats, Sprague-Dawley

2002